@4x.png?width=275&height=84&name=VersaTrial%20Text%20Logo%20-%20No%20Slogan%20(_CMYK)@4x.png "VersaTrial")
WILTON, Connecticut, July 11, 2023 – VersaTrial, the clinical research site enablement and engagement platform, is pleased to announce the appointment of Allison Kemner to its expanding advisory board.
Kemner, currently serving as the Vice President of Clinical Sciences and Operations at Tyra Biosciences, brings a wealth of experience and a unique perspective to VersaTrial. With her professional background in oncology nursing, she has gained experience across the clinical development sector, working with various companies from large pharmaceutical firms to small biotech startups. Kemner’s extensive work in Asia and across various areas of the clinical development spectrum further enriches her expertise.
"Allison's addition to our advisory board is a significant step forward for VersaTrial," said Mike Wenger, Founder and CEO of VersaTrial. "Insights from her unique blend of clinical and operational experience will be instrumental in furthering our efforts to improve clinical trial efficiency, quality, and collaboration.”
Kemner's dedication to broadening inclusivity and augmenting diversity in clinical trials is rooted in her deep understanding of the intersection of social structures, healthcare, and access barriers.
“I admire VersaTrial's commitment to alleviating site burden and enhancing the job satisfaction of site staff,” said Kemner. “I am eager to bring my experiences to the table and contribute to the mission of improving the efficiency and quality of clinical research, while promoting better collaboration and communication between sites and their study sponsors and CROs.”
About VersaTrial
VersaTrial is the all-in-one site portal that lets Sponsors and CROs improve clinical trial speed, quality, and collaboration. Enabling sites to spend more time with patients and less time navigating technology systems unlocks faster trials with fewer mistakes, wider tech adoption, and stronger site relationships. Only VersaTrial’s clinical trial site engagement platform provides Sponsors and CROs with real-time operational insights, bi-directional communication, and access management alerts to ensure measurable partner oversight and quality execution. Learn more at https://www.versatrial.io
-1.png)
Naor Chazan
Naor is Chief Marketing Officer at VersaTrial. Naor has spent his career in life sciences, working across a variety of areas including marketing research, eCOA technology, clinical trial transparency & disclosure, patient recruitment, and now at VersaTrial with a focus on site engagement and enablement. Naor is passionate about finding ways to use technology to improve the experiences of everyone involved in the clinical trial process. He believes that by working together and leveraging technology, we can make a meaningful impact on the future of healthcare.
Author
